Cell culture compositions with antioxidants and methods for polypeptide production
Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided.
1. A composition for the production of an antibody composition with reduced color intensity, comprising (i) a CHO cell comprising a nucleic acid encoding a recombinant antibody or a fragment thereof; and (ii) one or more of components selected from the group consisting of:
(a) hypotaurine at a concentration of at least about 0.0001 mM;
(b) s-carboxymethylcysteine at a concentration of at least about 0.0001 mM;
(c) butylated hydroxyanisole at a concentration of at least about 0.0001 mM; and
(d) quercitrin hydrate at a concentration of at least about 0.0001 mM.
2. The composition of claim 1 , wherein the composition comprises hypotaurine at a concentration from about 2.0 mM to about 50.0 mM.
3. The composition of claim 1 , wherein the composition comprises s-carboxymethylcysteine at a concentration from about 8.0 mM to about 12.0 mM.
4. The composition of claim 1 , wherein the composition comprises carnosine at a concentration from about 8.0 mM to about 12.0 mM.
5. The composition of claim 1 , wherein the composition comprises anserine at a concentration from about 3.0 mM to about 5.0 mM.
6. The composition of claim 1 , wherein the composition comprises butylated hydroxyanisole at a concentration from about 0.025 mM to about 0.040 mM.
7. The composition of claim 1 , wherein the composition comprises quercitrin hydrate at a concentration from about 0.010 mM to about 0.020 mM.
8. The composition of claim 1 , wherein the composition comprises aminoguanidine at a concentration from about 0.0003 mM to about 10 mM.
9. The composition of claim 1 , further comprising carnosine at a concentration of at least about 0.0001 mM.
10. The composition of claim 1 , further comprising anserine at a concentration of at least about 0.0001 mM.
11. The composition of claim 1 , further comprising aminoguanidine at a concentration of at least about 0.0003 mM.